Eton Pharmaceuticals names Danka Radosavljevic chief operating officer

• Eton Pharmaceuticals appointed Danka Radosavljevic as chief operating officer on July 31, 2026.
• Radosavljevic previously served as executive vice president, operations, overseeing quality, product development, regulatory, supply chain, information systems.
• She has been with the company since 2017.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-025506), on August 04, 2026, and is solely responsible for the information contained therein.